MAPT and Alzheimer disease: We first examined the level of phosphorylated tau (pTau) in the hippocampus and medial entorhinal cortex (MEC), since these regions play pivotal roles in the development of AD, and have been well‐recognized to be vulnerable for pTau accumulation and neurodegeneration (Braak et al., 2006).